aap Implantate AG has announced that the first six systems of the LOQTEQ trauma plating family of products has received FDA clearance, according to a news release.
This announcement follows clearance of the first LOQTEQ product in August 2012. LOQTEQ is an anatomic orthopedic trauma plating system designed to enable locking and compression with a single hole.
"With the first series of LOQTEQ products cleared in the United States, we are positioned to execute our commercial strategy for this significant market for our trauma business," said Biense Visser, CEO of aap Implantate AG, in the release. "LOQTEQ has been well-received by the medical community in Europe, and we anticipate similarly strong adoption in the United States as the system is made available. Given our high confidence in the surgeon and patient benefits of the technology, we are continuing to invest in the product family, with the expected launch of additional six LOQTEQ systems that will round out the portfolio planned for 2013."
The cleared LOQTEQ products include six plating systems to address orthopedic trauma injuries for small and large bone fragments, arms and legs
The first six LOQTEQ systems are expected to be commercially available in the United States in early 2013.
aap Implantate AG, a global medical device company focused on trauma products and biomaterials for the orthopedic market, is headquartered in Berlin.
Related Articles on FDA Clearances:
Blue Belt Technologies Receives FDA Clearance for Unicondylar Knee Replacement Surgery
Precision Spine Receives FDA Clearance for Minimally Invasive Access System
LENSAR Cataract Laser System Receives FDA Clearance for Corneal Incisions